Seven out of 1,000 outpatients received a prescription violating a black box warning, according to a study in the Archives of Internal Medicine (2/13/2006). Although few adverse drug events resulted among these patients (<1%), the researchers estimate that one in six patients who were prescribed a drug despite a black box warning had the potential for an adverse event.
Seven out of 1,000 outpatients received a prescription violating a black box warning, according to a study in the Archives of Internal Medicine (2/13/2006). Although few adverse drug events resulted among these patients (<1%), the researchers estimate that one in six patients who were prescribed a drug despite a black box warning had the potential for an adverse event.
The study's researchers analyzed the electronic medical records of 324,548 outpatients who received at least one prescription in an ambulatory practice in the greater Boston area in 2002. Of the 33,778 prescriptions, over 2,300 were written in violation of a black box warning. Nearly 91% of patients received a prescription for a condition for which the drug was not recommended. Some patients also received a prescription with a black box warning for drug-laboratory interaction (26.6%) and drug-drug interaction (3.3%). Moreover, patients who were 75 years of age or older, white, and female and who took more medications were more likely to receive a drug in violation of a black box warning than younger, male, nonwhite patients taking fewer medications.
The researchers acknowledge that black box warnings are often vague and difficult to understand. They may also be inconsistent with clinical practice guidelines. To increase adherence to these warnings, the researchers are calling on the Food and Drug Administration to make them more specific, readily understandable to prescribing providers, and consistent with commonly used practice guidelines.
Study: Plant-based diets lower hypertensive disorders of pregnancy risk
March 28th 2024A recent study suggests that adherence to plant-based diets significantly decreases the risk of developing hypertensive disorders of pregnancy, shedding light on dietary interventions for maternal health.
Read More
How genetic variables impact oral contraceptive use and VTE risk
March 27th 2024A comprehensive study delved into the interplay of polygenic and hereditary factors in venous thromboembolism risk among oral contraceptive users, shedding light on potential genetic markers for refined risk assessment and counseling.
Read More